The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM) securities during ...
Zacks Investment Research on MSN
Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption?
DexCom, Inc. DXCM is scheduled to report third-quarter 2025 resultson Oct. 30, after the closing bell. In the last reported ...
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the ...
DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated ...
Investing.com - UBS maintained its Buy rating and $106.00 price target on DexCom (NASDAQ:DXCM) following a Friday sell-off triggered by concerns about the company’s G7 continuous glucose monitoring ...
ORO VALLEY, Ariz. (KGUN) — Managing school and daily routines can be a lot for any young student, but for kindergartener Wyatt, who lives with Type 1 diabetes, having a support system makes all the ...
Some engine bays are as droolworthy as the cars they adorn, but under the twisty mechanical artistry lies an array of electronic wizardry to help run your car. The crankshaft position sensor is one of ...
Haupt is a health and wellness editor at TIME. Oura CEO Tom Hale On a Monday morning in late April, Oura CEO Tom Hale was feeling well-rested despite having stayed up later than usual the night before ...
An updated edition of the April 14, 2025 article. The global population is aging at an unprecedented pace, reshaping healthcare systems and economic planning across nations. Longer life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback